Cargando…

Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial

BACKGROUND: Gonorrhoea is a common sexually transmitted infection for which ceftriaxone is the current first-line treatment, but antimicrobial resistance is emerging. The objective of this study was to assess the effectiveness of gentamicin as an alternative to ceftriaxone (both combined with azithr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ross, Jonathan D C, Brittain, Clare, Cole, Michelle, Dewsnap, Claire, Harding, Jan, Hepburn, Trish, Jackson, Louise, Keogh, Matthew, Lawrence, Tessa, Montgomery, Alan A, Roberts, Tracy E, Sprange, Kirsty, Tan, Wei, Thandi, Sukhwinder, White, John, Wilson, Janet, Duley, Lelia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620599/ https://www.ncbi.nlm.nih.gov/pubmed/31056291 http://dx.doi.org/10.1016/S0140-6736(18)32817-4

Ejemplares similares

Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial
por: Brittain, Clare, et al.
Publicado: (2016)

The effectiveness of gentamicin in the treatment of Neisseria gonorrhoeae: a systematic review
por: Hathorn, Emma, et al.
Publicado: (2014)

Pharmacodynamics of Ceftriaxone, Ertapenem, Fosfomycin and Gentamicin in Neisseria gonorrhoeae
por: Gubenšek, Urša, et al.
Publicado: (2022)

In Vitro Efficacy of Gentamicin Alone and in Combination with Ceftriaxone, Ertapenem, and Azithromycin against Multidrug-Resistant Neisseria gonorrhoeae
por: Li, Xuechun, et al.
Publicado: (2021)

In Vitro Study of the Interaction of Gentamicin with Ceftriaxone and Azithromycin against Neisseria gonorrhoeae Using Agar Dilution Method
por: Xu, Wenqi, et al.
Publicado: (2022)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Japan
por: Ohnishi, Makoto, et al.
Publicado: (2011)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017
por: Katz, Alan R.
Publicado: (2018)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017
por: Lefebvre, Brigitte, et al.
Publicado: (2018)

Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina
por: Gianecini, Ricardo, et al.
Publicado: (2016)

Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis
por: Armstrong-Buisseret, Lindsay, et al.
Publicado: (2019)

Neisseria gonorrhoeae Aggregation Reduces Its Ceftriaxone Susceptibility
por: Wang, Liang-Chun, et al.
Publicado: (2018)

Structures of TOG1 and TOG2 from the human microtubule dynamics regulator CLASP1
por: Leano, Jonathan B., et al.
Publicado: (2019)

A Single Amino Acid Substitution in Elongation Factor G Can Confer Low-Level Gentamicin Resistance in Neisseria gonorrhoeae
por: Holley, Concerta L., et al.
Publicado: (2022)

A feasibility study investigating the acceptability and design of a multicentre randomised controlled trial of needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren’s contractures of the fingers (HAND-1): study protocol for a randomised controlled trial
por: Harrison, Eleanor, et al.
Publicado: (2017)

New Clinical Strain of Neisseria gonorrhoeae with Decreased Susceptibility to Ceftriaxone, Japan
por: Deguchi, Takashi, et al.
Publicado: (2016)

Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain
por: Lahra, Monica M., et al.
Publicado: (2018)

Conjunctivitis Caused by a Strain of Neisseria gonorrhoeae That Was Less Susceptible to Ceftriaxone
por: Iwata, Akira, et al.
Publicado: (2017)

Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USA
por: Papp, John R., et al.
Publicado: (2017)

Reliability of Genetic Alterations in Predicting Ceftriaxone Resistance in Neisseria gonorrhoeae Globally
por: Lin, Eric Yu, et al.
Publicado: (2022)

Tolerance to Ceftriaxone in Neisseria gonorrhoeae: Rapid Induction in WHO P Reference Strain and Detection in Clinical Isolates
por: Balduck, Margaux, et al.
Publicado: (2022)

Gentamicin susceptibility of Neisseria gonorrhoeae isolates from 7 provinces in China
por: Liu, Jing-Wei, et al.
Publicado: (2019)

The TOG protein Stu2 is regulated by acetylation
por: Greenlee, Matt A., et al.
Publicado: (2022)

An unconventional TOG domain is required for CLASP localization
por: Gareil, Nelly, et al.
Publicado: (2023)

Optimising recruitment to the HAND-1 RCT feasibility study: integration of the QuinteT Recruitment Intervention (QRI)
por: Husbands, Samantha, et al.
Publicado: (2020)

Identification of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain FC428, China
por: Chen, Shao-Chun, et al.
Publicado: (2019)

Randomised trials during a public health crisis, such as pandemic flu: a case study for a model of ‘off the shelf' ready-to-go trials
por: Whitham, Diane, et al.
Publicado: (2013)

Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018
por: Eyre, David W, et al.
Publicado: (2018)

Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022
por: Pleininger, Sonja, et al.
Publicado: (2022)

Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017
por: Terkelsen, David, et al.
Publicado: (2017)

Resistance of Neisseria gonorrhoeae isolates to beta-lactam antibiotics (benzylpenicillin and ceftriaxone) in Russia, 2015–2017
por: Shaskolskiy, Boris, et al.
Publicado: (2019)

Genetic Characterization and Enhanced Surveillance of Ceftriaxone-Resistant Neisseria gonorrhoeae Strain, Alberta, Canada, 2018
por: Berenger, Byron M., et al.
Publicado: (2019)

More mutation accumulation in Neisseria gonorrhoeae (NG) with susceptibility than that in NG with decreased susceptibility to ceftriaxone
por: Liang, Jing-Yao, et al.
Publicado: (2020)

Complete Genome Sequence of Ceftriaxone-Resistant Neisseria gonorrhoeae SS3160, Isolated in Tokyo, Japan
por: Miyake, Hirofumi, et al.
Publicado: (2020)

chTOG is a conserved mitotic error correction factor
por: Herman, Jacob A, et al.
Publicado: (2020)

Conducting a randomised trial during an influenza pandemic: an example of a trial set up and ‘hibernated’ ready to activate and recruit within 4 weeks
por: Brittain, Clare, et al.
Publicado: (2015)

Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial
por: Lim, Wei Shen, et al.
Publicado: (2017)

Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36(+ 0) weeks gestation
por: Armstrong-Buisseret, Lindsay, et al.
Publicado: (2018)

Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016
por: Day, Michaela J., et al.
Publicado: (2018)

Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015
por: Wind, Carolien M, et al.
Publicado: (2017)

Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016
por: George, C. R. Robert, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5qtsgv28bi2n3ibii2a7b1mnh5